Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Department of Rheumatology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Cancer Immunol Res. 2020 Apr;8(4):479-492. doi: 10.1158/2326-6066.CIR-19-0702. Epub 2020 Feb 19.
The success of checkpoint inhibitors in cancer treatment is associated with the infiltration of tissue-resident memory T (Trm) cells. In this study, we found that about 30% of tumor-infiltrating lymphocytes (TIL) in the tumor microenvironment of gastric adenocarcinoma were CD69CD103 Trm cells. Trm cells were low in patients with metastasis, and the presence of Trm cells was associated with better prognosis in patients with gastric adenocarcinoma. Trm cells expressed high PD-1, TIGIT, and CD39 and represented tumor-reactive TILs. Instead of utilizing glucose, Trm cells relied on fatty acid oxidation for cell survival. Deprivation of fatty acid resulted in Trm cell death. In a tumor cell-T-cell coculture system, gastric adenocarcinoma cells outcompeted Trm cells for lipid uptake and induced Trm cell death. Targeting PD-L1 decreased fatty acid binding protein (Fabp) 4 and Fabp5 expression in tumor cells of gastric adenocarcinoma. In contrast, the blockade of PD-L1 increased Fabp4/5 expression in Trm cells, promoting lipid uptake by Trm cells and resulting in better survival of Trm cells and . PD-L1 blockade unleashed Trm cells specifically in the patient-derived xenograft (PDX) mice. PDX mice that did not respond to PD-L1 blockade had less Trm cells than responders. Together, these data demonstrated that Trm cells represent a subset of TILs in the antitumor immune response and that metabolic reprogramming could be a promising way to prolong the longevity of Trm cells and enhance antitumor immunity in gastric adenocarcinoma.
检查点抑制剂在癌症治疗中的成功与组织驻留记忆 T(Trm)细胞的浸润有关。在这项研究中,我们发现胃腺癌肿瘤微环境中的肿瘤浸润淋巴细胞(TIL)中约有 30%为 CD69CD103 Trm 细胞。转移性患者中 Trm 细胞数量较低,且 Trm 细胞的存在与胃腺癌患者的预后较好相关。Trm 细胞表达高水平的 PD-1、TIGIT 和 CD39,代表肿瘤反应性 TIL。Trm 细胞不是利用葡萄糖,而是依赖脂肪酸氧化来维持细胞存活。剥夺脂肪酸会导致 Trm 细胞死亡。在肿瘤细胞-T 细胞共培养系统中,胃腺癌细胞与 Trm 细胞竞争脂质摄取,并诱导 Trm 细胞死亡。靶向 PD-L1 可降低胃腺癌肿瘤细胞中脂肪酸结合蛋白(Fabp)4 和 Fabp5 的表达。相反,PD-L1 的阻断增加了 Trm 细胞中 Fabp4/5 的表达,促进了 Trm 细胞的脂质摄取,从而提高了 Trm 细胞的存活能力。PD-L1 阻断在患者来源的异种移植(PDX)小鼠中特异性释放了 Trm 细胞。对 PD-L1 阻断无反应的 PDX 小鼠比有反应的小鼠中 Trm 细胞较少。总之,这些数据表明 Trm 细胞代表抗肿瘤免疫反应中 TIL 的一个亚群,代谢重编程可能是延长 Trm 细胞寿命和增强胃腺癌抗肿瘤免疫的一种有前途的方法。